Project news, updates, and announcements.
iThera Medical Announces Strategic Partnership to Enhance in vivo Imaging Capabilities with the MSOT
On 30 April 2019, iThera Medical GmbH and Invicro LLC, a Konica Minolta company, announced a unique partnership with the placement of the MSOT inVision platform in Invicro’s in vivo laboratory at its headquarters in Boston, USA. The companies will come together to uniquely offer pharmaceutical, biotechnology and academic sponsors services from the optoacoustic platform that will identify and quantify disease-related biomarkers at both a molecular and anatomical level through pre-clinical full body tomographic scans.
Invicro was founded in 2008 to improve the role and function of imaging in translational drug discovery and development across all therapeutic areas. Today, Invicro’s multi-disciplinary team provides solutions to pharmaceutical and biotech companies across all stages of the drug development pipeline (Phase 0-IV), all imaging modalities and all therapeutic areas, including neurology, oncology, cardiology, and pulmonary. Invicro’s quantitative biomarker services, advanced analytics and AI tools, and clinical operational services are backed by Invicro’s industry-leading software informatics platforms, VivoQuant and iPACS.
Read the full story in Global Banking & Finance here.
EUPHORIA recently appeared in the news stream of HealthEuropa.eu. Read the story, “Is there a way of advancing inflammatory bowel imaging technologies?” here.
Health Europa highlights the latest trends and developments in health and healthcare from across Europe. Their platform is a valuable news source to the health sector, allowing them to discuss research and innovation themes, health policy and new technologies. In addition, the website, HealthEuropa.eu has gained Google News approval. It features news, interviews and insightful commentary from leading figures, keeping readers informed and up to date on all aspects of health and care.
Our partner RAYFOS develops innovative image and data processing platforms for medical imaging and sensing applications. They are currently seeking a highly motivated Electrical Engineer with a professional or academic background in R&D projects and hands-on experience in software development.
The ideal candidate must have a degree in Electrical Engineering, a professional or academic background in R&D projects and experience in scientific SW development. He/she should be willing to take responsibilities and acquire new skills as a member of a distributed team of engineers.
For more information, click here. To express interest or for further information please email .
The EUPHORIA consortium met for a kick-off meeting at iThera Medical GmbH in Munich, Germany on February 1, 2019. iThera develops and markets biomedical imaging systems based on a novel biophotonics technology, Multispectral Optoacoustic Tomography (MSOT).
The project meeting included representatives from all five partners distributed across four European countries. After a welcome by EUPHORIA Coordinator Philipp Bell of iThera Medical and introductions around the table, Kylie O’Brien of Pintail Limited presented the project management objectives and tasks with attached deadlines. Frédéric Brochin from IMASONIC, a leader in ultrasonic technologies and solutions, facilitated discussion on optimizing the transducer. This process will incorporate the identification of technological and use requirements from clinicians.
Meeting delegates were taken on a facility tour led by Elena Mercep, a Senior Product Engineer at iThera Medical.
Vassilis Sarantos of RAYFOS presented plans for software adaptation. RAYFOS is a UK-based leader in optical engineering and real-time processing systems. Maximilian Waldner of University Hospital Erlangen provided interesting background information about inflammatory bowel diseases including disease complications, non-responders to drugs, the lack of biomarkers, clinical scores and the current standards of treatments. Above all, Max highlighted the clinical relevance of the EUPHORIA project. The University Hospital Erlangen has extensive experience with imaging technologies for medical diagnosis, as well as in the preclinical and clinical research of inflammatory diseases of the gastrointestinal tract. Their role within EUPHORIA is to further validate the new MSOT technology in the clinic. Certification and reimbursement plans were presented by Nina Dahlhaus of iThera Medical, and Danielle Nicholson of Pintail Limited facilitated a discussion which centred […]
iThera Medical to lead €2.3m research project to advance inflammatory bowel imaging technologies
The European Commission has awarded a €2.3 million ‘Fast Track to Innovation’ project grant to a consortium led by the Munich-based medical device company iThera Medical. Part of the EU’s Horizon 2020 research and innovation program, the aim of the grant is to improve the sensitivity and effectiveness of MSOT, Multispectral Optoacoustic Tomography, in detecting and managing inflammatory bowel diseases (IBD). Beyond technical improvements, the new project, ‘EUPHORIA’ (Enhancing Ultrasound and PHOtoacoustics for Recognition of Intestinal Abnormalities) will also support the transition of MSOT from clinical research use to routine diagnosis.
IBD is a common chronic condition, where patients suffer from recurring episodes of intestinal inflammation. Currently, it is diagnosed and monitored using endoscopy which causes patient discomfort and potentially severe complications such as colon perforation. MSOT has the potential for rapid, simple and non-invasive detection and monitoring of IBD, by pulsing laser light through the skin, and then interpreting the acoustic signals generated by light absorption in the colon wall. The system generates ultrasound and optoacoustic images that enable the assessment of inflammation in the colon wall. Because of its non-invasive nature, MSOT can be used more often, and thus could improve monitoring of patients in remission and during treatment. Dr. Philipp Bell, Chief Commercial Officer of iThera Medical, emphasizes the potential of MSOT in the context of EUPHORIA: “We are excited that the EUPHORIA funding will allow us to bring a non-invasive and fast diagnostic […]